Difference between revisions of "Part:BBa K567016"
(4 intermediate revisions by 3 users not shown) | |||
Line 2: | Line 2: | ||
<partinfo>BBa_K567016 short</partinfo> | <partinfo>BBa_K567016 short</partinfo> | ||
− | This biobrick is constructed by mutating the anticodon of tRNA | + | This biobrick is constructed by mutating the anticodon of tRNA<sup>Met</sup> to TCG (base pairing codon CGA). This tRNA can transfer fMet to CGA when it is used as the start codon. KanR gene with start codon substituted for CGA is used to testify the function of ''metY''-CGA. When this biobrick and ''metG''M(BBa_K567014) or ''metG''N(BBa_K567015) are co-transformed into the cell, the cells can survive on the LB Kan plate. |
Line 12: | Line 12: | ||
===Characterization of BBa_K567016=== | ===Characterization of BBa_K567016=== | ||
− | When this part, MetRS PT7-''metG''N (BBa_K567015)(or MetRS PT7-''metG''M (BBa_K567014)) and | + | When this part, MetRS PT7-''metG''N (BBa_K567015)(or MetRS PT7-''metG''M (BBa_K567014)) and KanR (BBa_K567020) are co-transformed into the cell, the cell is expected to survive Kanamycin. |
− | [[image:11SJTU-initial_codon_result.jpg|frame|center| | + | [[image:11SJTU-initial_codon_result.jpg|frame|center|Fig. Growth of ER2566 with a. ''metG''N + ''metY''-CGA, b. ''metG''M + ''metY''-CGA, c. + ''metG''N, d. + ''metG''M. Growth medium (left): LB Kana+Tet. Growth medium (right): LB Kana.]] |
− | Cell growth shows that the cells show | + | Cell growth shows that the cells show Kanamycin resistance only when both modified MetRS (''metG''N) and modified tRNA<sup>Met</sup>(''metY''-CGA) are transformed into the cell, proving that ''metG''N works well. |
For more information concerning this part, please see [http://2011.igem.org/Team:SJTU-BioX-Shanghai 2011 SJTU-BioX-iGEM] | For more information concerning this part, please see [http://2011.igem.org/Team:SJTU-BioX-Shanghai 2011 SJTU-BioX-iGEM] | ||
+ | |||
+ | Related Biobrick: | ||
+ | |||
+ | PT7-''metG''M ([https://parts.igem.org/wiki/index.php?title=Part:BBa_K567014 BBa_K567014]) | ||
+ | |||
+ | PT7-''metG''N ([https://parts.igem.org/wiki/index.php?title=Part:BBa_K567015 BBa_K567015]) | ||
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here |
Latest revision as of 03:32, 29 October 2011
metY-CGA
This biobrick is constructed by mutating the anticodon of tRNAMet to TCG (base pairing codon CGA). This tRNA can transfer fMet to CGA when it is used as the start codon. KanR gene with start codon substituted for CGA is used to testify the function of metY-CGA. When this biobrick and metGM(BBa_K567014) or metGN(BBa_K567015) are co-transformed into the cell, the cells can survive on the LB Kan plate.
Construction of BBa_K567016
metY-CGA: We have cloned operon metY containing tRNAMet from E.coli to pACYC184. The anticodon of tRNAMet was mutated to TCG (base pairing codon CGA).
Characterization of BBa_K567016
When this part, MetRS PT7-metGN (BBa_K567015)(or MetRS PT7-metGM (BBa_K567014)) and KanR (BBa_K567020) are co-transformed into the cell, the cell is expected to survive Kanamycin.
Cell growth shows that the cells show Kanamycin resistance only when both modified MetRS (metGN) and modified tRNAMet(metY-CGA) are transformed into the cell, proving that metGN works well.
For more information concerning this part, please see [http://2011.igem.org/Team:SJTU-BioX-Shanghai 2011 SJTU-BioX-iGEM]
Related Biobrick:
PT7-metGM (BBa_K567014)
PT7-metGN (BBa_K567015)
Sequence and Features
- 10INCOMPATIBLE WITH RFC[10]Illegal PstI site found at 183
- 12INCOMPATIBLE WITH RFC[12]Illegal PstI site found at 183
- 21COMPATIBLE WITH RFC[21]
- 23INCOMPATIBLE WITH RFC[23]Illegal PstI site found at 183
- 25INCOMPATIBLE WITH RFC[25]Illegal PstI site found at 183
- 1000COMPATIBLE WITH RFC[1000]